Correction: BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity

Affiliations

• ¹ Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
• ² School of Electrical Engineering of Zhengzhou University, Zhengzhou, China.
• ³ Center for Frontier Medical Engineering of Chiba University, Chiba, Japan.
• ⁴ Department of Urology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
• ⁵ Department of Urology, Guizhou Provincial People's Hospital, Guiyang, China.
• ⁶ Department of Urology, Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China.
• ⁷ Department of Pharmacy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
• ⁸ Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. 2008yangguosheng@sina.com.
• ⁹ Department of Biotherapy, Zhongshan Hospital, Fudan University, Shanghai, China. www0228@126.com.
• ¹⁰ Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. ericyelin@tongji.edu.cn.